THURSDAY, Aug. 17, 2023 (HealthDay News) — Two recently approved treatments offer newfound hope for patients in the early stages of Alzheimer’s disease, but most people who could benefit will likely be deemed ineligible, a new study finds. Alzheimer’s affects about 6.7 million Americans age 65 and older. But onlyContinue Reading

THURSDAY, Aug. 17, 2023 (HealthDay News) — The idea of “doing your own research” didn’t begin with the pandemic, but new research suggests that those who follow that ideology have been more likely to believe COVID misinformation. “We had heard the phrase a lot before,” prior to the pandemic, saidContinue Reading

WEDNESDAY, Aug. 16, 2023 (HealthDay News) — All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation’s leading pediatrics group said. The American Academy of Pediatrics (AAP) urged that access to the new medication, called nirsevimab, be equitable. RSV is common, contagious andContinue Reading

MONDAY, Aug. 14, 2023 (HealthDay News) — Psilocybin, the active ingredient in “magic” mushrooms, is getting renewed interest as a potential treatment for various health conditions. Now, a new research review argues that migraines should be added to that list. Psilocybin mushrooms have long been used recreationally as hallucinogens —Continue Reading

MONDAY, Aug. 14, 2023 (HealthDay News) — For people with severe alcohol use disorder, a new gene therapy trial could lead to an effective treatment that would involve chemically rebalancing the area of the brain associated with addiction. “With alcohol alone, there’s generally more than 100,000 deaths [in the UnitedContinue Reading